# Anticoagulation in AF Ablation and Effects on Neurocognitive Function

> **NCT02120560** · PHASE4 · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Atrial Fibrillation
- Cerebrothromboembolus
- Neurocognitive Function

## Interventions

- **PROCEDURE:** Atrial Fibrillation Ablation

## Key facts

- **NCT ID:** NCT02120560
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02120560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02120560, "Anticoagulation in AF Ablation and Effects on Neurocognitive Function". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02120560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*